Johnson & Johnson buy tbackenh
Summary
This prediction ended on 06.08.18 with a price of €118.71. With a performance of -3.54%, the BUY prediction by tbackenh finished with a loss. tbackenh has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Johnson & Johnson | -1.686% | -1.686% | -8.815% | -4.212% |
iShares Core DAX® | 3.054% | -1.396% | 15.789% | 12.675% |
iShares Nasdaq 100 | 4.389% | -5.391% | 29.906% | 39.325% |
iShares Nikkei 225® | 5.386% | -3.105% | 16.065% | 8.150% |
iShares S&P 500 | 2.955% | -3.011% | 25.903% | 37.650% |
According to tbackenh what are the pros and cons of Johnson & Johnson for the foreseeable future?
Pros
Cons
Comments by tbackenh for this prediction
In the thread Johnson & Johnson diskutieren
Johnson & Johnson
Defensiver Dividendentitel, der seit 1961 seine Ausschüttungen stets steigern konnte. Für mich ein Basisinvestment.
Stopped prediction by tbackenh for Johnson & Johnson
Johnson & Johnson
27.04.22
27.04.23
27.04.23
Johnson & Johnson
30.06.15
16.07.15
16.07.15
Johnson & Johnson
28.11.14
23.01.15
23.01.15